Abstract

Troponin assays are a valuable tool in early risk stratification of patients with ischaemic sounding chest pain. However, troponin is often measured outside of this clinical context. The finding of a raised troponin value may be misinterpreted as an acute coronary syndrome leading to unnecessary and sometimes dangerous anticoagulation. This article looks at some of the considerations which need to be made when interpreting the significance of a raised troponin value.

[download-attachments container="div" style="list" display_icon="1" display_count="1" display__size="0"]

References

1. Omland T. New features of troponin testing in different clinical settings. J Intern Med 2010; 268: 207– 217.
2. Babuin L and Jaffe AS. Troponin: the biomarker of choice for the detection of cardiac injury. CMAJ 2005; 173(10): 1191–1202.
3. Sorichter S, Mair J, Koller A, Gebert W, et al. Skeletal troponin I as a marker of exercise-induced muscle damage. Journal of Applied Physiology. 1997; 83(4): 1076–1082.
4. Thygesen K, Alpert JS, White HD, et al. Universal definition of myocardial infarction J Am Coll Cardiol. 2007; 50: 2173–2195.
5. Scottish Intercollegiate Guidelines Network. Sign guideline 97. Acute Coronary Syndromes. A National Clinical Guideline. Edinburgh;2007.
6. Torbicki A, Perrier A, Konstantinides S, Agnelli G, Galiè N, Pruszczyk P, Bengel F, Brady AJ, Ferreira D, Janssens U, et al; ESC Committee for Practice Guidelines (CPG). Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J. 2008; 29(18): 2276–315.
7. Roche Diagnostics GmbH. Troponin T hs (high sensitive). Roche Diagnostics, 2008.
8. Omland T, de Lemos JA, Sabatine MS, et al. A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med. 2009; 361(26): 2538–2547.
9. Kelley WE, Januzzi JL, and Christenson RH Increases of Cardiac Troponin in Conditions other than Acute Coronary Syndrome and Heart Failure Clinical Chemistry 2009; 55(12): 2098–2112.
10. Jacobs LH, van de Kerkhof J, Mingels AM, Kleijnen VW, van der Sande FM, Wodzig WK, Kooman JP, van Dieijen-Visser MP. Haemodialysis patients longitudinally assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and cardiac troponin I assays. Ann Clin Biochem 2009; 46: 283–290.
11. Vasile VC, Saenger AK, Kroning JM, and Jaffe AS. Biological and Analytical Variability of a Novel High-Sensitivity Cardiac Troponin T Assay Clin Chem 2010; 56: 1086–1090.
12. Agewall S, Giannitsis E, Jernberg T, and Katus H. Troponin elevation in coronary vs. non-coronary disease Eur Heart J. 2011; 32(4): 404–11.
13. Røsjø H, Varpula M, Hagve T-A, Karlsson S, Ruokonen E, Pettilä V, Omland T and The FINNSEPSIS Study Group. Circulating high sensitivity troponin T in severe sepsis and septic shock: distribution, associated factors, and relation to outcome Intensive Care Med 2011; 37: 77–85.
14. Bukkapatnam RN, Robinson M, Turnipseed S, Tancredi D, Amsterdam E, Srivatsa UN. Relationship of myocardial ischemia and injury to coronary artery disease in patients with supraventricular tachycardia. Am J Cardiol 2010; 106: 374–377.
15. Aventis Pharma Limited. Plavix™ data sheet #64311v8. Date of preparation 14 November 2006.
16. Gruberg L. OASIS 5: Efficacy and Safety of Fondaparinux vs Enoxaparin in ACS Patients [Internet]. Available at http://www.medscape.com/ viewarticle/513986. Accessed 12/1/2011.